Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02297191 · ClinicalTrials.gov registry record · Phase 1
Ultrasound Guided Local Anesthetic Block: Thoracolumbar Interfascial Plane
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT02297191 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 10 participants.
The verdict
NCT02297191, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the effectiveness of a new approach to numbing (anesthetizing) nerves in the back and to measure how far the area of anesthesia extends on the skin of the back.
Interventions
- DRUG Ropivicaine
- PROCEDURE Thoracolumbar Interfascial Plane Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-07 |
| Est. Completion | 2014-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02297191
The ClinicalTrials.gov registry entry for NCT02297191 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropivicaine is the first listed.
NCT02297191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02297191 about?
NCT02297191 is a clinical study titled "Ultrasound Guided Local Anesthetic Block: Thoracolumbar Interfascial Plane". The purpose of the study is to determine the effectiveness of a new approach to numbing (anesthetizing) nerves in the back and to measure how far the area of anesthesia extends on the skin of the back.
What is the current status of trial NCT02297191?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2014-07. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02297191?
The interventions under investigation include: Ropivicaine (DRUG), Thoracolumbar Interfascial Plane Block (PROCEDURE).
Who is sponsoring clinical trial NCT02297191?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.